Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience

ConclusionsTTP shorter than 4  months after first-line treatment, NLR greater than 3 and CA-19.9 level higher than the upper limit of normal at the beginning of 2L were associated with shorter overall survival. We developed a prognostic score that classifies patients with advanced PDAC into three prognostic groups after progres sion to the first-line. This score could help in the decision-making for 2L treatment.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research